Risk factors and prediction models of lymph node metastasis in papillary thyroid carcinoma based on clinical and imaging characteristics

References

• Shin J, Kim MH, Yoon KH, et al. Relationship between metabolic syndrome and thyroid nodules in healthy Koreans. Korean J Intern Med. 2016;31(1):98–105.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Lim H, Devesa SS, Sosa JA, et al. Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. JAMA. 2017;317(13):1338–1348.
   PubMed Web of Science ®Google Scholar
• Conzo G, Docimo G, Pasquali D, et al. Predictive value of nodal metastases on local recurrence in the management of differentiated thyroid cancer. Retrospective clinical study. BMC Surg. 2013;2(Suppl 2):S3.
   Web of Science ®Google Scholar
• Suh CH, Baek JH, Choi YJ, et al. Performance of CT in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid Cancer: a systematic review and meta-analysis. AJNR Am J Neuroradiol. 2017;38(1):154–161.
   PubMed Web of Science ®Google Scholar
• Shen H, Lv G, Ke L, et al. The clinical value of new scoring system of cervical lymph node. Ultrasound Q. 2019;35(3):269–274.
   PubMed Web of Science ®Google Scholar
• Zhao H, Li H. Meta-analysis of ultrasound for cervical lymph nodes in papillary thyroid cancer: diagnosis of central and lateral compartment nodal metastases. Eur J Radiol. 2019;112:14–21.
   PubMed Web of Science ®Google Scholar
• Adam MA, Pura J, Goffredo P, et al. Presence and number of lymph node metastases are associated with compromised survival for patients younger than age 45 years with papillary thyroid Cancer. J Clin Oncol. 2015;33(21):2370–2375.
   PubMed Web of Science ®Google Scholar
• Jeon MJ, Kim WG, Choi YM, et al. Recent changes in the clinical outcome of papillary thyroid carcinoma with cervical lymph node metastasis. J Clin Endocrinol Metab. 2015;100(9):3470–3477.
   PubMed Web of Science ®Google Scholar
• Zhang M, Tufano RP, Russell JO, et al. Ultrasound-guided radiofrequency ablation versus surgery for low-risk papillary thyroid microcarcinoma: results of over 5 years’ follow-up. Thyroid. 2020;30(3):408–417.
   PubMed Web of Science ®Google Scholar
• Choi Y, Jung SL, Pasquali D. Efficacy and safety of thermal ablation techniques for the treatment of primary papillary thyroid microcarcinoma: a systematic review and meta-analysis. Thyroid. 2020;30(5):720–731.
   PubMed Web of Science ®Google Scholar
• Conzo G, Docimo G, Mauriello C, Mauriello C, et al. The current status of lymph node dissection in the treatment of papillary thyroid cancer. A literature review. La Clinica terapeutica. 2013;164(4):e343–6.
   PubMed Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.
   PubMed Web of Science ®Google Scholar
• Liu W, Cheng R, Ma Y, Ma Y, et al. Establishment and validation of the scoring system for preoperative prediction of central lymph node metastasis in papillary thyroid carcinoma. Sci Rep. 2018;8(1):6962.
   PubMed Web of Science ®Google Scholar
• Li X, Zhang H, Zhou Y, et al. Risk factors for central lymph node metastasis in the cervical region in papillary thyroid carcinoma: a retrospective study. World J Surg Oncol. 2021;19(1):138.
   PubMed Web of Science ®Google Scholar
• Zheng CM, Ji YB, Song CM, et al. Number of metastatic lymph nodes and ratio of metastatic lymph nodes to total number of retrieved lymph nodes are risk factors for recurrence in patients with clinically node negative papillary thyroid carcinoma. Clinical and Experimental Otorhinolaryngology. 2018;11(1):58–64.
   PubMed Web of Science ®Google Scholar
• Xue S, Zhang L, Pang R, et al. Predictive factors of central-compartment lymph node metastasis for clinical n0 papillary thyroid carcinoma with strap muscle invasion. Front Endocrinol (Lausanne). 2020;11:511.
   PubMed Web of Science ®Google Scholar
• Zhou TH, Lin B, Wu F, et al. Extranodal extension is an independent prognostic factor in papillary thyroid cancer: a propensity score matching analysis. Front Endocrinol (Lausanne). 2021;12:759049.
   PubMed Web of Science ®Google Scholar
• Kwak JY, Han KH, Yoon JH, et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology. 2011;260(3):892–899.
   PubMed Web of Science ®Google Scholar
• Mazzaferri EL, Massoll N. Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin. Endocr Relat Cancer. 2002;9(4):227–247.
   PubMed Web of Science ®Google Scholar
• Yang Z, Heng Y, Lin J, et al. Nomogram for predicting central lymph node metastasis in papillary thyroid cancer: a retrospective cohort study of two clinical centers. Cancer Res Treat. 2020;52(4):1010–1018.
   PubMed Web of Science ®Google Scholar
• Wu Q, Li Y, Wang Y, et al. Sonographic features of primary tumor as independent predictive factors for lymph node metastasis in papillary thyroid carcinoma. Clin Transl Oncol. 2015;17(10):830–834.
   PubMed Web of Science ®Google Scholar
• Shindo H, Amino N, Ito Y, et al. Papillary thyroid microcarcinoma might progress during pregnancy. Thyroid. 2014;24(5):840–844.
   PubMed Web of Science ®Google Scholar
• Thompson AM, Turner RM, Hayen A, et al. A preoperative nomogram for the prediction of ipsilateral central compartment lymph node metastases in papillary thyroid cancer. Thyroid. 2014;24(4):675–682.
   PubMed Web of Science ®Google Scholar
• Shukla N, Osazuwa-Peters N, Megwalu UC. Association Between Age and Nodal Metastasis in Papillary Thyroid Carcinoma. Otolaryngol Head Neck Surg. 2021;165(1):43–49.
   PubMed Web of Science ®Google Scholar
• Zhao W, He L, Zhu J, et al. A nomogram model based on the preoperative clinical characteristics of papillary thyroid carcinoma with Hashimoto’s thyroiditis to predict central lymph node metastasis. Clin Endocrinol (Oxf). 2021;94(2):310–321.
   PubMed Web of Science ®Google Scholar
• Xu SY, Yao JJ, Zhou W, et al. Clinical characteristics and ultrasonographic features for predicting central lymph node metastasis in clinically node-negative papillary thyroid carcinoma without capsule invasion. Head Neck. 2019;41(11):3984–3991.
   PubMed Web of Science ®Google Scholar
• Moses W, Weng J, Khanafshar E, et al. Multiple genetic alterations in papillary thyroid cancer are associated with younger age at presentation. J Surg Res. 2010;160(2):179–183.
   PubMed Web of Science ®Google Scholar
• Vriens MR, Moses W, Weng J, et al. Clinical and molecular features of papillary thyroid cancer in adolescents and young adults. Cancer. 2011;117(2):259–267.
   PubMed Web of Science ®Google Scholar
• Shayganfar A, Hashemi P, Esfahani MM, et al. Prediction of thyroid nodule malignancy using thyroid imaging reporting and data system (TIRADS) and nodule size. Clin Imaging. 2020;60(2):222–227.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Zheng K, Zhang H, et al. The clinicopathologic differences of central lymph node metastasis in predicting lateral lymph node metastasis and prognosis in papillary thyroid cancer associated with or without Hashimoto’s thyroiditis. Tumour Biol. 2016;37(6):8037–8045.
   PubMedGoogle Scholar
• Tang T, Li J, Zheng L, et al. Risk factors of central lymph node metastasis in papillary thyroid carcinoma: a retrospective cohort study. Int J Surg. 2018;54(Pt A):129–132.
   PubMed Web of Science ®Google Scholar
• Wang L, Chen J, Yuan, et al. Lymph node metastasis of papillary thyroid carcinoma in the context of Hashimoto’s thyroiditis. BMC Endocr Disord. 2022;22(1):12.
   PubMed Web of Science ®Google Scholar
• Meryem Atak Tel B, Kahveci G, Satilmis Bilgin, et al. Platelet to lymphocyte ratio in differentiation of benign and malignant thyroid nodules.Exp Biomed Res. 2021;4(2):148–153. DOI: 10.30714/j-ebr.2021267978.
   Google Scholar
• Deng Y, Zhang J, Zou G, et al. Peripheral Blood Inflammatory Markers Can Predict Benign and Malignant Thyroid Nodules. Int J Endocrinol. 2022;2022:2319660.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Xia F, Wang W, et al. The systemic immune-inflammation index-based model is an effective biomarker on predicting central lymph node metastasis in clinically nodal-negative papillary thyroid carcinoma. Gland Surg. 2021;10(4):1368–1373.
   PubMed Web of Science ®Google Scholar
• Bedel C, Korkut M, Can NLR AHH. PLR and LMR be used as prognostic indicators in patients with pulmonary embolism? A commentary. Bosn J Basic Med Sci. 2021;21(4):501.
   PubMed Web of Science ®Google Scholar
• Wu Y, Chen Y, Yang X, et al. Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus. Int Immunopharmacol. 2016;36:94–99.
   PubMed Web of Science ®Google Scholar
• Yu QA, Ma DK, Liu KP,Liu KP, et al. Clinicopathologic risk factors for right paraesophageal lymph node metastasis in patients with papillary thyroid carcinoma. J Endocrinol Invest. 2018;41(11):1333–1338.
   PubMed Web of Science ®Google Scholar
• Sun F, Zou Y, Huang L, et al. Nomogram to assess the risk of central cervical lymph node metastasis in patients with clinical n0 papillary thyroid Carcinoma. Endocr Pract. 2021;27(12):1175–1182.
   PubMed Web of Science ®Google Scholar
• Feng JW, Hong LZ, Wang F, et al. A nomogram based on clinical and ultrasound characteristics to predict central lymph node metastasis of papillary Thyroid Carcinoma. Front Endocrinol (Lausanne). 2021;12:666315.
   PubMed Web of Science ®Google Scholar
• Chen W, Li G, Li Z, et al. Evaluation of plasma exosomal miRNAs as potential diagnostic biomarkers of lymph node metastasis in papillary thyroid carcinoma. Endocrine. 2022;75(3):846–855.
   PubMed Web of Science ®Google Scholar
• Dai D, Tan Y, Guo L, et al. Identification of exosomal miRNA biomarkers for diagnosis of papillary thyroid cancer by small RNA sequencing. Eur J Endocrinol. 2020;182(1):111–121.
   PubMed Web of Science ®Google Scholar
• Wu F, Li F, Lin X, et al. Exosomes increased angiogenesis in papillary thyroid cancer microenvironment. Endocr Relat Cancer. 2019;26(5):525–538.
   PubMed Web of Science ®Google Scholar
• Liu C, Zhang L, Liu Y, et al. Value of pyruvate carboxylase in thyroid fine-needle aspiration wash-out fluid for predicting papillary thyroid cancer lymph node metastasis. Front Oncol. 2021;11:643416.
   PubMed Web of Science ®Google Scholar